Comparative Binding of ¹²⁵I-and ^99mTc-Labeled Native and Glycated Low-Density Lipoprotein to Human Microvascular Endothelial Cells-Potential for Atherosclerosis Imaging?

REFERENCES

• Steinbrecher U P, Lougheed M, Kwan Wing-Cheung, Dirks M. Recognition of low density lipoprotein by scavenger receptor of macrophages results from derivatization of apolipoprotein B by products of fatty acid peroxidation. J Biol Chem 1989; 264: 15216–15223
   PubMed Web of Science ®Google Scholar
• Költringer P, Jürgens G. A dominant role of lipoprotein(a) in the investigation and evaluation of parameters indicating the development of cervical atherosclerosis. Atherosclerosis 1985; 58: 187–198
   PubMed Web of Science ®Google Scholar
• Kawamori R, Yamasaki Y, Matsushima H, Nishizawa H, Nao K, Hougaku H, Maeda H, Handa N, Matsumoto M, Kamada T. Prevalence of carotid atherosclerosis in diabetic patients. Ultrasound high-resolution B-mode imaging on carotid arteries. Diabetes Care 1992; 15: 1290–1294
   PubMed Web of Science ®Google Scholar
• Hunt J V, Smith C CT, Wolff S P. Autoxidative glycosylation and possible involvement of peroxides and free radicals in LDL modification by glucose. Diabetes 1990; 39: 1420–1424
   PubMed Web of Science ®Google Scholar
• Cominacini L, Garbin U, Pastorino A M. Increased susceptibility of LDL to in vitro oxidation in patients with insulin-dependent and non-insulin-dependent diabetes mellitus. Diabetes Res 1994; 26: 173–184
   PubMedGoogle Scholar
• Bucala R, Makita Z, Koschinsky T, Cerami A, Vlassara H. Lipid advanced glycosylation: Pathway for lipid oxidation in vivo. Proc Natl Acad Sci USA 1993; 90: 6434–6438
   PubMed Web of Science ®Google Scholar
• Menzel E J, Sobal G, Staudinger A. The role of oxidative stress in the long-term glycation of LDL. Biofactors 1997; 6: 111–124
   PubMed Web of Science ®Google Scholar
• Napoli C, Triggiani M, Palumbo G, Condorelli M, Chiariello M, Ambrosio G. Glycosylation enhances oxygen radical-induced modifications and decreases acetylhydrolase activity of human low density lipoprotein. Basic Res Cardiol 1997; 92: 96–105
   PubMed Web of Science ®Google Scholar
• Sobal G, Menzel E J, Sinzinger H. Why is glycated LDL more sensitive to oxidation than native LDL? A comparative study. Prostaglandins Leukot Essent Fatty Acids 2000; 63: 177–186
   PubMed Web of Science ®Google Scholar
• Bucala R, Makita Z, Vega G, Grundy S, Koschinsky T, Cerami A, Vlassara H. Modification of low density lipoprotein by advanced glycation end products contributes to the dyslipidemia of diabetes and renal insufficiency. Proc Natl Acad Sci USA 1994; 91: 9441–9445
   PubMed Web of Science ®Google Scholar
• Brownlee M. Glycation and diabetic complication. Diabetes 1994; 43: 836–841
   PubMed Web of Science ®Google Scholar
• Jinnouchi Y, Sano H, Nagai R, Hakamata H, Kodama T, Suzuki H, Yoshida M, Ueda S, Horiuchi S. Glycolaldehyde-modified low density lipoprotein leads macrophages to foam cells via the macrophage scavenger receptor. J Biochem Tokyo 1998; 123: 1208–1217
   PubMed Web of Science ®Google Scholar
• Dobrian A, Lazar V, Tirziu D, Simionescu M. Increased macrophage uptake of irreversibly glycated albumin modified-low density lipoproteins of normal and diabetic subjects is mediated by non-saturable mechanisms. Biochim Biophys Acta 1996; 1317: 5–14
   PubMed Web of Science ®Google Scholar
• Lees R S, Lees A M, Strauss H W. External imaging of human atherosclerosis. J Nucl Med 1983; 24: 154–156
   PubMed Web of Science ®Google Scholar
• Lees R S, Garabedian H D, Lees A M, Schumacher D J, Miller A, Isaacsohn J L, Strauss H W. Tc-99m low density lipoproteins: Preparation and biodistribution. J Nucl Med 1985; 26: 1056–1062
   PubMed Web of Science ®Google Scholar
• Mc Carthy P A. New approaches to atherosclerosis: An overview. Med Res Rev 1993; 13: 139–159
   PubMed Web of Science ®Google Scholar
• Yamashina H. Evaluation of biodistribution and imaging of atherosclerotic lesions using 111In-labeled low-density lipoprotein. Kaku-Igaku 1993; 30: 769–778
   PubMedGoogle Scholar
• Virgolini I, Angelberger P, O'Grady J, Sinzinger H. Low density lipoprotein labelling characterizes experimentally induced atherosclerotic lesions in rabbits in vivo as to presence of foam cells and endothelial coverage. Eur J Nucl Med 1991; 8: 944–947
   Google Scholar
• Lees A M, Lees R S, Schoen F J, Isaacsohn J L, Fischman A J, McKusick K A, Strauss H W. Imaging human atherosclerosis with 99mTc-labeled low density lipoproteins. Arteriosclerosis 1988; 8: 461–470
   PubMedGoogle Scholar
• Iuliano L, Signore A, Vallabajosula S, Camastra C, Ronga G, Alessandri C, Sbarigia E, Fiorani P, Violi F. Preparation and biodistribution of 99mtechnetium-labelled oxidized LDL in man. Atherosclerosis 1996; 126: 131–141
   PubMed Web of Science ®Google Scholar
• Tsimikas S, Palinski W, Halpern S E, Yeung D W, Curtiss L K, Witztum J L. Radiolabeled MDA2, an oxidation-specific, monoclonal antibody, identifies native atherosclerotic lesions in vivo. J Nucl Cardiol 1999; 6: 41–53
   PubMed Web of Science ®Google Scholar
• Havel R J, Eder H A, Bragdon J H. The distribution and chemical composition of ultracentrifugally separeted lipoproteins in human serum. J Clin Invest 1985; 34: 1345–1353
   Web of Science ®Google Scholar
• Lowry O H, Rosebrough N J, Farr A L, Randall R J. Protein measurement with Folin phenol reagent. J Biol Chem 1951; 193: 265–275
   PubMed Web of Science ®Google Scholar
• Panteghini M, Bonora R, Pagani F. Determination of glycated apolipoprotein B in serum by a combination of affinity chromatography and immunonephelometry. Ann Clin Biochem 1994; 31: 544–549
   PubMed Web of Science ®Google Scholar
• Buege J A, Aust S D. Lactoperoxidase-catalyzed lipid peroxidation of microsomal and artifical membranes. Biochim Biophys Acta 1976; 444: 192–201
   PubMed Web of Science ®Google Scholar
• McConahey P J, Dixon F J. A method of trace iodination of proteins for immunologic studies. Int Arch Allergy 1966; 29: 185–187
   Web of Science ®Google Scholar
• Tontonoz P, Nagy L, Alvarez J G, Thomazy V A, Evans R M. PPARγ promotes monocyte-macrophage differentiation and uptake of oxidized LDL. Cell 1998; 93: 241–252
   PubMed Web of Science ®Google Scholar
• Van der Kooij M A, von der Mark E M, Kruijt J K, van Velzen A, van Berkel T J, Morand O H. Human monocyte-derived macrophages express an approximately 120 kD ox-LDL binding protein with strong identity to CD68. Arterioscler Thromb Vasc Biol 1997; 17: 3107–3116
   PubMed Web of Science ®Google Scholar
• Atsma D E, Feitsma R I, Camps J, van't Hooft F M, van der Wall E E, Nieuwzenhuizen W, Pauwels E K. Potential of 99mTc-LDLs labeled with two different methods for scintigraphic detection of experimental atherosclerosis in rabbits. Arterioscler Thromb 1993; 13: 78–83
   PubMed Web of Science ®Google Scholar
• Lees A M, Lees R S. 99mTc-labeled LDL: Receptor recognition and intracellular sequestration of radiolabel. J Lipid Res 1991; 32: 1–8
   PubMed Web of Science ®Google Scholar
• Virgolini I, Angelberger P, Li S R, Koller F, Pidlich J, Lupattelli G, Sinzinger H. Indium-111-labeled low-density lipoprotein binds with higher affinity to the human liver as compared to iodine-123-low-density-labeled lipoprotein. J Nucl Med 1991; 32: 2132–2138
   PubMed Web of Science ®Google Scholar
• Moriwaki H, Kume S, Sawamura T, Aoyama T, Hoshikawa H, Ochi H, Nishi E, Masaki T, Kita T. Ligand specificity of LOX-1, a novel endothelial receptor for oxidized low density lipoprotein. Arterioscler Thromb Vasc Biol 1998; 18: 1541–1547
   PubMed Web of Science ®Google Scholar